MEDX · Horizon Kinetics Medical ETF ETF
Listed Funds Trust
$36.69
-1.06%
At close · Sep 4
Net assets $19,076,938
Holdings33
1 month
+3.01%
Year to date
+10.51%
52-week range
$28.87–$37.90
30-session avg volume
2,221
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Open-end / ETF
- SEC series
- S000078972
- Report date
- Jun 30, 2026
- Holdings coverage
- Full reported portfolio
Portfolio concentration
Top 10 holdings72.41%
Calculated only when the SEC filing is stored with complete portfolio coverage.
Asset allocation
EC92.64%
STIV9.19%
Country allocation
US77.40%
CH10.33%
GB8.57%
IE5.53%
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| Eli Lilly & Co | LLY | $3,521,526 | 18.46% |
| US BANK MMDA - USBGFS 7 | $1,752,681 | 9.19% | |
| AbbVie Inc | ABBV | $1,689,008 | 8.85% |
| Novartis AG | NVS | $1,314,567 | 6.89% |
| Johnson & Johnson | JNJ | $1,066,674 | 5.59% |
| Alkermes PLC | $1,054,816 | 5.53% | |
| AstraZeneca PLC | $950,944 | 4.98% | |
| Ionis Pharmaceuticals Inc | IONS | $864,578 | 4.53% |
| Bristol-Myers Squibb Co | BMY | $843,787 | 4.42% |
| Merck & Co Inc | MRK | $754,552 | 3.96% |
| Amgen Inc | AMGN | $746,691 | 3.91% |
| Alnylam Pharmaceuticals Inc | ALNY | $652,633 | 3.42% |
| Biogen Inc | BIIB | $588,980 | 3.09% |
| Pfizer Inc | PFE | $545,364 | 2.86% |
| GSK PLC | GSK | $516,127 | 2.71% |
| CRISPR Therapeutics AG | $503,295 | 2.64% | |
| Regeneron Pharmaceuticals Inc | REGN | $392,830 | 2.06% |
| Beam Therapeutics Inc | BEAM | $287,876 | 1.51% |
| Galectin Therapeutics Inc | GALT | $217,932 | 1.14% |
| Intellia Therapeutics Inc | NTLA | $212,921 | 1.12% |
| Sandoz Group AG | 799926100 | $152,023 | 0.80% |
| Replimune Group Inc | REPL | $139,305 | 0.73% |
| Vanda Pharmaceuticals Inc | VNDA | $138,606 | 0.73% |
| Haleon PLC | HLN | $114,843 | 0.60% |
| Lantern Pharma Inc | LTRN | $104,934 | 0.55% |
| Editas Medicine Inc | EDIT | $89,683 | 0.47% |
| GE HealthCare Technologies Inc | GEHC | $53,768 | 0.28% |
| Bicycle Therapeutics PLC | BCYC | $53,356 | 0.28% |
| Viatris Inc | VTRS | $49,577 | 0.26% |
| Allogene Therapeutics Inc | ALLO | $34,894 | 0.18% |
| Pacific Biosciences of Califor | PACB | $16,914 | 0.09% |
| Decoy Therapeutics Inc | DCOY | $149 | 0.00% |
| Pathos AI Inc | $0 | 0.00% |